News & Promotions

Provide total solutions for Life Science applications together with global partners. We are constantly striving to be more
connected, forward-looking and customer-focused to deliver best results.

News & Promotions

News

[Creative Diagnostics] Optimal Reagents for Your Successful Development of Diphtheria Vaccines

관리자 2023.04.14 10:20 조회 874 추천 14
기흥banner-1200.png



logo-380.png

230413-1.png


Reagents for
Diphtheria Vaccine Development

Diphtheria is caused primarily by toxigenic Corynebacterium diphtheriae strains and occasionally by toxigenic C. ulcerans and C. pseudotuberculosis strains. The acute respiratory infection caused by Diphtheria is generally characterized by local growth of the bacterium in the pharynx with pseudomembrane formation. Then, systemic dissemination of diphtheria toxin (DT) induces lesions in distant organs. Diphtheria toxin is an exotoxin produced by the pathogen that inhibits protein synthesis and causes cell death. The disease may remain manageable, but in more severe cases, lymph nodes in the neck may swell, making breathing and swallowing more difficult. Diphtheria can also lead to paralysis of the eyes, neck, throat, or respiratory muscles. The CDC recommends diphtheria vaccination for infants, children, teens, and adults.


 Creative Diagnostics has released new diphtheria vaccine-related products, including antibodies, antigens and ELISA kits. The development and testing of diphtheria vaccines has been enhanced using these reagents suitable for routine diagnosis of diphtheria and epidemiological surveys.



230413-2.png


Performance


230413-3.png

Products Available


230413-4.png

230413-5.png



230221-4.png



(주)엘바이오시스템은 Creative Diagnostics의 한국공식대리점입니다.

제품의 주문 및 관련정보가 필요하시면 전화, 이메일로 문의해 주세요.